Related Experiment Video
Updated: Jun 7, 2026

Strategies for Tracking Anastasis, A Cell Survival Phenomenon that Reverses Apoptosis
Published on: February 16, 2015
Cytoplasmic ASPP1 inhibits apoptosis through the control of YAP
Arnaud M Vigneron1, Robert L Ludwig, Karen H Vousden
1The Beatson Institute for Cancer Research, Bearsden, Glasgow G61 1BD, United Kingdom.
Abstract:
The ASPP (apoptosis-stimulating protein of p53) family of proteins can function in the nucleus to modulate the transcriptional activity of p53, with ASPP1 and ASPP2 contributing to the expression of apoptotic target genes. In this study, we describe a new function for cytoplasmic ASPP1 in controlling YAP (Yes-associated protein)/TAZ. ASPP1 can inhibit the interaction of YAP with LATS1 (large tumor suppressor 1), a kinase that phosphorylates YAP/TAZ and promotes cytoplasmic sequestration and protein degradation. This function of ASPP1 therefore enhances nuclear accumulation of YAP/TAZ and YAP/TAZ-dependent transcriptional regulation. The consequence of YAP/TAZ activation by ASPP1 is to inhibit apoptosis, in part through the down-regulation of Bim expression, leading to resistance to anoikis and enhanced cell migration. These results reveal a potential oncogenic role for cytoplasmic ASPP1, in contrast to the tumor-suppressive activity described previously for nuclear ASPP1.
Related Concept Videos
The Intrinsic Apoptotic Pathway
Caspases
The Extrinsic Apoptotic Pathway
Apoptosis
The JAK-STAT Signaling Pathway
Anaphase Promoting Complex

